Aveo Forum: Community User: Gambler10101

Das ist schon mehr, als verscheissern

Läuft ja hier

AVEO Announces Proposed Public Offering of Common Stock https://www.businesswire.com/news/home/20210322005742/en/AVEO-Announces-Proposed-Public-Offering-of-Common-Stock ...today announced that it has commenced an underwritten public offering of 5,000,000 shares of its common stock. In connection with the offering, AVEO intends to grant the underwriters a 30-day option to purchase up to an additional 750,000 shares of its common stock. All of the shares in the offering are to be sold by AVEO. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The net proceeds of the offering are expected to be used for working capital and general corporate purposes, including to support commercialization activities relating to FOTIVDA (tivozanib) and to advance AVEO’s pipeline.  ...

Ufff

Diese Aktie. !. Jeden Tag im minus

AVEO Oncology Announces U.S. Commercial Availability of FOTIVDA (tivozanib) for the Treatment of Adult Patients With Relapsed or Refractory Advanced Renal Cell Carcinoma Ahead of Previous Guidance https://www.businesswire.com/news/home/20210322005202/en/AVEO-Oncology-Announces-U.S.-Commercial-Availability-of-FOTIVDA%C2%AE-tivozanib-for-the-Treatment-of-Adult-Patients-With-Relapsed-or-Refractory-Advanced-Renal-Cell-Carcinoma-Ahead-of-Previous-Guidance - FOTIVDA is the First Therapy Approved for Adults with Relapsed or Refractory Advanced RCC Following Two or More Prior Systemic Therapies – - AVEO ACE Patient Support Program in Place to Assist with Access, Affordability, and Treatment Adherence - ...

Aktie Tot 💀

Hier ist ja die Hölle los 😅

AVEO: Q4 Earnings Snapshot https://www.sfchronicle.com/business/article/AVEO-Q4-Earnings-Snapshot-16030505.php AVEO Oncology Reports Full Year 2020 Financial Results and Provides Business Update https://www.businesswire.com/news/home/20210316006015/en/AVEO-Oncology-Reports-Full-Year-2020-Financial-Results-and-Provides-Business-Update – FOTIVDA® (tivozanib) Approved for Adult Patients with Relapsed or Refractory Advanced Renal Cell Carcinoma Following Two or More Prior Systemic Therapies; AVEO Plans to Make FOTIVDA Available to Patients in the U.S. by March 31, 2021 – - Entered Clinical Trial Collaboration and Supply Agreement with Bristol Myers Squibb for Planned Pivotal Phase 3 TiNivo-2 Study of FOTIVDA in Combination with OPDIVO® (nivolumab); Trial Expected to Commence Mid-2021 - – Enrollment Complete in Phase 2 Open Label Randomized Study of Ficlatuzumab in HNSCC; Results and Phase 3 Decision on Track for Mid-2021 – - Regained Ex-North American Rights to AV-203; AVEO Now Holds Global Rights to Three Clinical Assets in Addition to FOTIVDA North American Rights - - $20M Tranche Drawdown Complete in Connection with FOTIVDA Approval Under Amended Hercules Loan Agreement - – Announced IP Strategy to Potentially Extend FOTIVDA Exclusivity to November 2028 – ....

OK danke

Aktuell hier sehr zermürbend, 4 gute News innerhalb 1 Woche und es geht nur runter 😉

Aktiensplitt

Kurze Frage, ich bin hier nicht investiert aber eins interessiert mich. War diese Aktie wirklich Mal bei über 200€? Und warum der Absturz? Hat irgendwer Infos oder Vorgeschichte.

Anteilig hatte ich nach dem Anstieg realisiert. Aber für den Rest mag ich es noch nicht so festlegen. Ist ja nicht so, dass mich Aveo nicht schon den ein oder anderen Nerv gekostet hat bisher 🙃🙄😅

Bleibtst Du drin Summer ? Ich bin etwas deprimiert 😅 was soll passieren, dass wir uns bewegen, nur ein BO kann da helfen 😉

Die kleine Aufwärtsbewegung vorhin wurde ja auch kollektiv vom Markt runtergezogen 🙃